| Scrip Code | 544088 |
|---|---|
| NSE Symbol | MEDIASSIST |
| MSEI Symbol | NOTLISTED |
| ISIN | INE456Z01021 |
| Name of company | MEDI ASSIST HEALTHCARE SERVICES LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2026 |
| Date of end of financial year | 31-03-2027 |
| Date of board meeting when results were approved | 08-08-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 03-08-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | First quarter |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | |
| Segment Reporting | Single segment |
| Description of single segment | Health Management Services |
| Start date and time of board meeting | 08-08-2026 13:45:00 |
| End date and time of board meeting | 08-08-2026 15:00:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? | Yes |
| No. of times funds raised during the quarter | 1 |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? | No |
| No default on loans and debt securities | |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-06-2026 | 30-06-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| 1 | Income | ||
| Revenue from operations | 5,898.40 | 5,898.40 | |
| Other income | 702.80 | 702.80 | |
| Total income | 6,601.20 | 6,601.20 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0.00 | 0.00 |
| (b) | Purchases of stock-in-trade | 0.00 | 0.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0.00 | 0.00 |
| (d) | Employee benefit expense | 1,320.00 | 1,320.00 |
| (e) | Finance costs | 111.20 | 111.20 |
| (f) | Depreciation, depletion and amortisation expense | 488.10 | 488.10 |
| (f) | Other Expenses | ||
| 1 | Other expenses | 2,912.00 | 2,912.00 |
| Total other expenses | 2,912.00 | 2,912.00 | |
| Total expenses | 4,831.30 | 4,831.30 | |
| 3 | Total profit before exceptional items and tax | 1,769.90 | 1,769.90 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | 1,769.90 | 1,769.90 |
| 6 | Tax expense | ||
| 7 | Current tax | 317.80 | 317.80 |
| 8 | Deferred tax | 136.90 | 136.90 |
| 9 | Total tax expenses | 454.70 | 454.70 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 1,315.20 | 1,315.20 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 1,315.20 | 1,315.20 |
| 17 | Other comprehensive income net of taxes | 58.70 | 58.70 |
| 18 | Total Comprehensive Income for the period | 1,373.90 | 1,373.90 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | |||
| Total profit or loss, attributable to non-controlling interests | |||
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | |||
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | |||
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 3,735.10 | 3,735.10 | |
| Face value of equity share capital | 5 | 5 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 1.76 | 1.76 | |
| Diluted earnings (loss) per share from continuing operations | 1.76 | 1.76 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 1.76 | 1.76 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 1.76 | 1.76 | |
| 24 | Debt equity ratio | 0 | 0 |
| 25 | Debt service coverage ratio | 0 | 0 |
| 26 | Interest service coverage ratio | 0 | 0 |
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | None |
|---|
| Debt equity ratio | The company has repaid all borrowings in FY 2025-26. There is no outstanding debt or interest/principal obligation for the period ended Q1 June 2026; hence, DSCR and ISCR are not applicable. |
|---|---|
| Debt service coverage ratio | The company has repaid all borrowings in FY 2025-26. There is no outstanding debt or interest/principal obligation for the period ended Q1 June 2026; hence, DSCR and ISCR are not applicable. |
| Interest service coverage ratio | The company has repaid all borrowings in FY 2025-26. There is no outstanding debt or interest/principal obligation for the period ended Q1 June 2026; hence, DSCR and ISCR are not applicable. |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-04-2026 | 01-04-2026 | |||||
| Date of end of reporting period | 30-06-2026 | 30-06-2026 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Standalone | Standalone | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-06-2026 | 30-06-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Re-measurement of defined benefit plans | (11.80) | (11.80) |
| 2 | Fair value changes in equity instruments through other comprehensive income | 63.70 | 63.70 |
| Total Amount of items that will not be reclassified to profit and loss | 51.90 | ||
| 2 | Income tax relating to items that will not be reclassified to profit or loss | (6.80) | (6.80) |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | 58.70 | 58.70 |
| Mode of Fund Raising | Preferential Issues |
|---|---|
| Description of mode of fund raising (Applicable in case of others is selected) | |
| Date of Raising Funds | 10-10-2025 |
| Amount Raised | 19,800.00 |
| Report filed for Quarter ended | 30-06-2026 |
| Monitoring Agency | Applicable |
| Monitoring Agency Name, if applicable | CARE Ratings Limited |
| Is there a Deviation / Variation in use of funds raised | No |
| If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders | |
| If Yes, Date of shareholder Approval | |
| Explanation for the Deviation / Variation | false |
| Comments of the Audit Committee after review | There is no deviation/variation in use of funds raised. Proceeds from Investment in Mutual Funds of Rs.7.50 crore were credited to the monitoring account on 29-06-2026. This redemption was made for the purpose approved by the Board. This Rs.7.5 crore was transferred to the current account of the company for the purpose approved by the board. Documents were submitted to Bank for payment on 29-06-2026. Since this transaction involves forex payments, debit from our account took 2~3 days once the money got credited to our account. Out of Rs.7.5 crore, Rs.4.72 crore got debited on 30-06-2026 and balance Rs.2.78 crore got debited on 01-07-2026 morning. Funds lying in current account were used for approved purpose only. |
| Comments of the auditors, if any | false |
| Sr. | Original Object | Modified Object, if any | Original Allocation | Modified allocation, if any | Funds Utilised | Amount of Deviation/Variation for the quarter according to applicable object | Remarks if any |
| 1 | For undertaking investment in Medi Assist Insurance TPA Pvt. Limited, a wholly-owned material subsidiary of the Company (“Subsidiary”), in the form of equity/quasi equity, debt/loan instruments, which will be utilized by the Subsidiary to prepay/repay, in full or part, all or a portion of certain outstanding borrowings availed by the Subsidiary from banks, nonbanking finance companies and other lenders, if any. (“Investment in Subsidiary for Debt Prepayment/ Repayment”) | Not applicable | 15,000.00 | 0.00 | 14,840.00 | 0.00 | Rs. 1.60 crore not utilized during the quarter |
| 2 | Up to 25% (twenty-five percent) of the Issue Proceeds will be utilised for general corporate purposes, which includes, inter alia, meeting ongoing general corporate exigencies and contingencies, expenses and investments of the Company as applicable in such a manner and proportion as may be decided by the Board from time to time, and/or any other general purposes as may be permissible under applicable laws (“General Corporate Purposes”) | Not applicable | 4,800.00 | 0.00 | 472.00 | 0.00 | The company utilized Rs.4.72 crore towards acquisition of additional stake in its subsidiary, Mayfair We Care Limited, UK as approved by board and 43.28 crore is not utilized. |
| Name of signatory | Sandeep Daga |
| Designation of person | Chief Financial Officer |
| Place | Bengaluru |
| Date | 08-08-2026 |